Fulgent Genetics, Inc. Q3 FY2025 Earnings Call

Fulgent Genetics, Inc. (FLGT)

Earnings Call FY2025 Q3 Call date: 2025-11-07 Concluded

Quarter scorecard

Revenue

$84.07M

+17.2% YoY

Gross margin

42.2%

+4.9 pp YoY

Net income

-$6.61M

Laboratory Services $83.93M

+17%

Therapeutic Development $138,000